Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ed Gane"'
Autor:
Joanne M. Carson, Sebastiano Barbieri, Evan Cunningham, Eric Mao, Marc van derValk, Jürgen K. Rockstroh, Margaret Hellard, Arthur Kim, Sanjay Bhagani, Jordan J. Feld, Ed Gane, Maria C. Thurnheer, Julie Bruneau, Elise Tu, Gregory J. Dore, Gail V. Matthews, Marianne Martinello, the REACT study group
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 9, Pp n/a-n/a (2023)
Abstract Introduction Exploration of sexual and drug use behaviours following treatment for recent hepatitis C virus (HCV) is limited. This analysis modelled behavioural trajectories following treatment for recent HCV and assessed reinfection. Method
Externí odkaz:
https://doaj.org/article/b3262514476c4462adada919df457c2f
Autor:
Jess Howell, MBBS(Hons), PhD, MSc(Epi), PGradDip(PH), Avik Majumdar, MBBS(Hons), MPHTM, PhD, Michael Fink, MBBS, Mandy Byrne, PhD, Geoff McCaughan, MBBS, PhD, Simone I. Strasser, MBBS, PhD, Michael Crawford, MBBS, MD, Peter Hodgkinson, MBBS, Katherine A. Stuart, MBBS, PhD, Caroline Tallis, MBBS(Hons), John Chen, MBBS, Alan Wigg, MBBS, PhD, Robert Jones, MBBS, PhD, Bryon Jaques, BASc, MD, PhD, Gary Jeffrey, MBBS, PhD, Leon Adams, MBBS, PhD, Michael C. Wallace, MBBS, PhD, Ed Gane, MBChB, MD, Alex Thompson, MBBS(Hons), PhD, Paul Gow, MBBS, PhD
Publikováno v:
Transplantation Direct, Vol 8, Iss 8, p e1345 (2022)
Background. Prevalence of concurrent liver diseases among liver transplant recipients and impact on posttransplant outcomes are unknown. Methods. This retrospective study included adult liver transplants between January 1‚ 1985‚ and December 31
Externí odkaz:
https://doaj.org/article/a266723e4cfd4c57b8a48a7e0974bf66
Autor:
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, Ed Gane, Valerie Paradis, Ann Cleverly, Claire Smith, Shawn T Estrem, Michael Man, Shuaicheng Wang, Michael M Lahn, Eric Raymond, Karim A Benhadji, Sandrine Faivre
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253671 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0222259.].
Externí odkaz:
https://doaj.org/article/2995cf4239874373a2d5d26500aa62c2
Autor:
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, Ed Gane, Valerie Paradis, Ann Cleverly, Claire Smith, Shawn T Estrem, Michael Man, Shuaicheng Wang, Michael M Lahn, Eric Raymond, Karim A Benhadji, Sandrine Faivre
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0222259 (2020)
BackgroundTransforming growth factor beta (TGF-β) signalling is involved in the development of hepatocellular carcinoma (HCC). We followed changes in biomarkers during treatment of patients with HCC with the TGF-βRI/ALK5 inhibitor galunisertib.Meth
Externí odkaz:
https://doaj.org/article/b94571adec37493990e021bf220fbe7b
Autor:
Qinglu Cheng, Evan B. Cunningham, Sophy Shih, Janaki Amin, Julie Bruneau, Adelina A. Artenie, Jeff Powis, Alain H. Litwin, Curtis Cooper, Olav Dalgard, Margaret Hellard, Philip Bruggmann, Philippa Marks, Karine Lacombe, Catherine Stedman, Phillip Read, Behzad Hajarizadeh, Adrian J. Dunlop, Brian Conway, Jordan J. Feld, Gregory J. Dore, Jason Grebely, Gregory Dore, Sione Crawford, Tracy Swan, Jude Byrne, Melanie Lacalamita. Coordinating Centre—Amanda Erratt, Evan Cunningham, Pip Marks, Ineke Shaw, Sharmila Siriragavan, Sophie Quiene, Kathy Petoumenos, Patrick Schmid, Erika Castro, Alberto Moriggia, Jean-Pierre Daulouede, Christopher Fraser, Jordan Feld, Ed Gane, Gail Matthews, Adrian Dunlop, Ian Kronborg, David Shaw, Alain Litwin, Brianna Norton, Maria Christine Thurnheer, Martin Weltman, Philip Read, John Dillon, Simone Kessler, Cornelia Knapp, Lorenza Oprandi, Paola Messina, Marzia Pantic, Manuela Le Cam, Cecilia Maitre, Jessica Andreassen, Ingunn Melkeraaen, Merete Moen Tollefsen, Hannah Pagarigan, Rozalyn Milne, Kate Mason, Diana Kaznowski, Lily Zou, Rachel Bouchard, Barbara Kotsoros, Miriam Muir, Jessica Milloy, Victoria Oliver, Tracy Noonan, Alison Sevehon, Susan Hazelwood, Michelle Hall, Michelle Hagenauer, Rachel Liddle, Catherine Ferguson, Linda Agyemang, Hiral Patel, Irene Soloway, Orlando Cerocchi, Melanie Lacalamita, Vincenzo Fragomeli, Rosie Gilliver, Rebecca Lothian, Shirley Cleary, Linda Johnston, Sarah Middleton, Ronald D’Amico, Barbara McGovern, Jonathan Anderson, Ze Zhong, Fiona Keane, Fernando Tatsch, Diana Brainard, John McHutchison
Publikováno v:
Value in Health. 26:883-892
Autor:
Amin J Roberts, Alicia Lim, Jonathan R Bishop, Ed Gane, Elizaveta Rakhmanova, William Wong, Helen M Evans
Publikováno v:
Journal of Paediatrics and Child Health. 59:537-541
Autor:
Josef Wagner, Lilly Yuen, Margaret Littlejohn, Vitina Sozzi, Kathy Jackson, Ross Martin, Thomas Aeschbacher, Vithika Suri, Susanna K. Tan, Becket Feierbach, Anuj Gaggar, Patrick Marcellin, Maria Buti Ferret, Harry L. A. Janssen, Ed Gane, Niamh Meagher, David J. Price, Darren Wong, Alexander T. Thompson, Peter A. Revill
Publikováno v:
Alimentary Pharmacology & Therapeutics. 57:509-523
We investigated associations between hepatitis B virus (HBV) genome-length haplotype number (HN) at baseline in subjects with HBeAg-positive chronic hepatitis B (CHB), and the likelihood of achieving functional cure during direct-acting antiviral the
Autor:
Seng Gee Lim, Thomas F. Baumert, Carolina Boni, Ed Gane, Massimo Levrero, Anna S. Lok, Mala K. Maini, Norah A. Terrault, Fabien Zoulim
Functional cure of chronic hepatitis B (CHB) - or hepatitis B surface antigen (HBsAg) loss after 24 weeks off therapy - is now the goal of treatment, but is rarely achieved with current therapy. Understanding the hepatitis B virus (HBV) life cycle an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19073981817bf345e66e41742f7bf106
Publikováno v:
Journal of hepatology. 76(6)
Functional cure of hepatitis B is defined as sustained undetectable circulating HBsAg and HBV DNA after a finite course of treatment. Barriers to HBV cure include the reservoirs for HBV replication and antigen production (covalently closed circular D
Autor:
Gail V. Matthews, Sanjay Bhagani, Marc Van der Valk, Juergen Rockstroh, Jordan J. Feld, Andri Rauch, Christine Thurnheer, Julie Bruneau, Arthur Kim, Margaret Hellard, David Shaw, Ed Gane, Mark Nelson, Patrick Ingiliz, Tanya L. Applegate, Jason Grebely, Phillipa Marks, Marianne Martinello, Kathy Petoumenos, Gregory J. Dore, Marc van der Valk, Greg Dore, Pip Marks, Gail Matthews, Tanya Applegate, Jordan Feld, Jürgen Rockstroh, Sophia Amjad, Elise Tu, Mahshid Tamaddoni, Maria Christine Thurnheer, Yvonne Gilleece, Chris Fraser, Alberto Moriggia, Thomas Lutz, Juhi Moon, Phillip Read, Arthur Y. Kim, Andrew Ustianowski, Christiane Cordes, Joe Sasadeusz, Mark Hull, Dominique Braun
Publikováno v:
Matthews, Gail V; Bhagani, Sanjay; Van der Valk, Marc; Rockstroh, Juergen; Feld, Jordan J; Rauch, Andri; Thurnheer, Christine; Bruneau, Julie; Kim, Arthur; Hellard, Margaret; Shaw, David; Gane, Ed; Nelson, Mark; Ingiliz, Patrick; Applegate, Tanya L; Grebely, Jason; Marks, Phillipa; Martinello, Marianne; Petoumenos, Kathy; Dore, Gregory J; ... (2021). Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection. Journal of hepatology, 75(4), pp. 829-839. Elsevier 10.1016/j.jhep.2021.04.056
J Hepatol
Journal of hepatology, 75(4), 829-839. Elsevier
J Hepatol
Journal of hepatology, 75(4), 829-839. Elsevier
Background & Aims Shortened duration therapy for acute and recent HCV infection has been shown to be highly effective in several small non-randomised studies with direct-acting antiviral regimens; however, large randomised studies are lacking. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56cb0f6e8b73a263af7310a4cfd284e8
https://boris.unibe.ch/156581/1/1-s2.0-S0168827821003366-main.pdf
https://boris.unibe.ch/156581/1/1-s2.0-S0168827821003366-main.pdf